Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus

被引：7
|
作者：
Nepal, Desh [1 ,2 ]
Gazeley, David [1 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Rheumatol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Rheumatol, Hub Collaborat Med, 8701 Watertown Plan Rd,6th Floor, Milwaukee, WI 53226 USA
来源：
RHEUMATOLOGY | 2023年 / 62卷 / 12期
关键词：
IL-6; inhibition; SLE; tocilizumab; sirukumab; OF-RHEUMATOLOGY GUIDELINE; PHASE PROTEIN RESPONSE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; MURINE LUPUS; T-CELLS; INTERLEUKIN-6; TOCILIZUMAB; EFFICACY; RECEPTOR;
D O I：
10.1093/rheumatology/kead416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Interleukin-6 is one of the cytokines implicated in murine and human SLE. Only a few small studies have investigated IL-6 inhibition in human SLE. Currently, there are no studies registered in clinicaltrials.gov to assess the IL-6 targeted therapy in SLE, yet its role in the future remains to be defined. This narrative review analyses these and potential areas of future studies with IL-6 targeted therapy in SLE. A video abstract is available for this article and can be viewed at https://doi.org/10.1093/rheumatology/kead416.
引用
收藏
页码：3804 / 3810
页数：7
相关论文
共 50 条
  • [1] Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus
    Hirohata, Shunsei
    Kikuchi, Hirotoshi
    ACR OPEN RHEUMATOLOGY, 2021, 3 (01) : 42 - 49
  • [2] The role of IL-6 and IL-6 blockade in COVID-19
    Potere, Nicola
    Batticciotto, Alberto
    Vecchie, Alessandra
    Porreca, Ettore
    Cappelli, Antonella
    Abbate, Antonio
    Dentali, Francesco
    Bonaventura, Aldo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (06) : 601 - 617
  • [3] Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
    M Linker-Israeli
    DJ Wallace
    J Prehn
    D Michael
    M Honda
    KD Taylor
    M Paul-Labrador
    N Fischel-Ghodsian
    PA Fraser
    JR Klinenberg
    Genes & Immunity, 1999, 1 : 45 - 52
  • [4] Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
    Linker-Israeli, M
    Wallace, DJ
    Prehn, J
    Michael, D
    Honda, M
    Taylor, KD
    Paul-Labrador, M
    Fischel-Ghodsian, N
    Fraser, PA
    Klinenberg, JR
    GENES AND IMMUNITY, 1999, 1 (01) : 45 - 52
  • [5] Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients
    Tang, Yamei
    Tao, Huai
    Gong, Yuji
    Chen, Fang
    Li, Cunyan
    Yang, Xiudeng
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (07): : 410 - 415
  • [6] Tocilizumab Therapy for Treatment-Resistant Systemic Lupus Erythematosus with Elevated IL-6 and CRP Levels: a Case Report
    Sandeep Yadav
    Vishnu Sharma
    C. Balakrishnan
    SN Comprehensive Clinical Medicine, 5 (1)
  • [7] IL-6 Directed Therapy in Transplantation
    Miller, Cynthia L.
    Madsen, Joren C.
    CURRENT TRANSPLANTATION REPORTS, 2021, 8 (03) : 191 - 204
  • [8] IL-6 Directed Therapy in Transplantation
    Cynthia L. Miller
    Joren C. Madsen
    Current Transplantation Reports, 2021, 8 : 191 - 204
  • [9] Role of IL-6 in systemic angiogenesis of the lung
    McClintock, JY
    Wagner, EM
    JOURNAL OF APPLIED PHYSIOLOGY, 2005, 99 (03) : 861 - 866
  • [10] Interleukin (IL-6) Immunotherapy
    Tanaka, Toshio
    Narazaki, Masashi
    Kishimoto, Tadamitsu
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (08):
12345